Alps ETF Trust · net assets $240M · 110 holdings as of August 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 100.0% · STIV: 0.0% · DE: 0.0%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $4.46M | $15M | $29.1M |
| Reinvestment | $0 | $0 | $0 |
| Redemptions | $5.23M | $0 | $0 |
| Net realized gain (non-derivative) | $8.79M | -$2.75K | -$2.83K |
| Net unrealized appreciation (non-derivative) | $20.7M | -$3.76M | $9.33M |
The three months of the reporting period, as filed; month 3 ends August 31, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Crinetics Pharmaceuticals Inc EC | $11M | 4.60% |
| Apogee Therapeutics Inc EC | $10.3M | 4.29% |
| Cg Oncology Inc EC | $8.17M | 3.41% |
| Travere Therapeutics Inc EC | $7.59M | 3.16% |
| Xenon Pharmaceuticals Inc EC | $7.17M | 2.99% |
| Dianthus Therapeutics Inc EC | $7.11M | 2.96% |
| Oruka Therapeutics Inc EC | $6.88M | 2.87% |
| Acadia Pharmaceuticals Inc EC | $6.1M | 2.54% |
| Edgewise Therapeutics Inc EC | $5.54M | 2.31% |
| Definium Therapeutics Inc EC | $5.34M | 2.23% |
| Dyne Therapeutics Inc EC | $5.18M | 2.16% |
| Veradermics Inc EC | $5.06M | 2.11% |
| Relay Therapeutics Inc EC | $4.93M | 2.05% |
| Denali Therapeutics Inc EC | $4.65M | 1.94% |
| Amylyx Pharmaceuticals Inc EC | $4.63M | 1.93% |
| Ideaya Biosciences Inc EC | $4.34M | 1.81% |
| Structure Therapeutics Inc EC | $4.02M | 1.68% |
| Tarsus Pharmaceuticals Inc EC | $3.93M | 1.64% |
| Celldex Therapeutics Inc EC | $3.83M | 1.60% |
| Immunome Inc EC | $3.83M | 1.60% |
| Disc Medicine Inc EC | $3.7M | 1.54% |
| Newamsterdam Pharma Co Nv EC | $3.65M | 1.52% |
| Mbx Biosciences Inc EC | $3.61M | 1.50% |
| Zai Lab Ltd EC | $3.42M | 1.42% |
| Viridian Therapeutics Inc EC | $3.15M | 1.31% |
| Sellas Life Sciences Group Inc EC | $3.06M | 1.28% |
| Biocryst Pharmaceuticals Inc EC | $3.04M | 1.27% |
| Vera Therapeutics Inc EC | $3.02M | 1.26% |
| Nektar Therapeutics EC | $2.98M | 1.24% |
| Rapport Therapeutics Inc EC | $2.87M | 1.19% |
| Nuvation Bio Inc EC | $2.86M | 1.19% |
| Mineralys Therapeutics Inc EC | $2.79M | 1.16% |
| Sarepta Therapeutics Inc EC | $2.74M | 1.14% |
| Palvella Therapeutics Inc EC | $2.68M | 1.12% |
| Zenas Biopharma Inc EC | $2.51M | 1.05% |
| Vericel Corp EC | $2.51M | 1.05% |
| Xencor Inc EC | $2.49M | 1.04% |
| Agios Pharmaceuticals Inc EC | $2.47M | 1.03% |
| Kailera Therapeutics Inc EC | $2.46M | 1.03% |
| Generate Biomedicines Inc EC | $2.41M | 1.00% |
| Stoke Therapeutics Inc EC | $2.4M | 1.00% |
| Lakefront Biotherapeutics Nv EC | $2.28M | 0.95% |
| Immunocore Holdings PLC EC | $2.28M | 0.95% |
| Compass Pathways PLC EC | $2.25M | 0.94% |
| Taysha Gene Therapies Inc EC | $2.02M | 0.84% |
| Bicara Therapeutics Inc EC | $1.87M | 0.78% |
| Tyra Biosciences Inc EC | $1.84M | 0.77% |
| Maze Therapeutics Inc EC | $1.81M | 0.76% |
| Arrivent Biopharma Inc EC | $1.73M | 0.72% |
| Lb Pharmaceuticals Inc EC | $1.68M | 0.70% |
| Immatics Nv EC | $1.58M | 0.66% |
| Meiragtx Holdings PLC EC | $1.57M | 0.65% |
| Seaport Therapeutics Inc EC | $1.57M | 0.65% |
| Alto Neuroscience Inc EC | $1.54M | 0.64% |
| Mannkind Corp EC | $1.53M | 0.64% |
| Vor Biopharma Inc EC | $1.49M | 0.62% |
| Corvus Pharmaceuticals Inc EC | $1.46M | 0.61% |
| Kura Oncology Inc EC | $1.39M | 0.58% |
| Candel Therapeutics Inc EC | $1.19M | 0.49% |
| Geron Corp EC | $1.18M | 0.49% |
Showing top 60 of 110 holdings.
Loading...